The Spain Burn Care Market was valued at $32.2 Million in 2024 and projected to reach to $39.8 Million by 2029, representing a compound annual growth rate of 3.8%. Spain's burn care market demonstrates steady growth potential driven by enhanced healthcare infrastructure investments and growing recognition of specialized burn treatment importance.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Spain's burn care market is valued at USD 32.2 million in 2024, with projections reaching USD 39.8 million by 2029, representing a steady CAGR of 3.8%.
Spain's advancing healthcare infrastructure and increased investment in specialized wound and burn treatment facilities are driving market expansion and improving patient outcomes.
Spain's CAGR of 3.8% is below the global average of 5.6%, indicating a more conservative but stable market growth trajectory compared to international markets.
Rising awareness of advanced burn care treatments and technologies among Spanish healthcare providers is accelerating adoption of modern wound management solutions.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | BIOLOGICS (Product) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 5.6% from 2024 to 2029 |
| Largest Segment | SECOND-DEGREE BURNS (PARTIAL-THICKNESS BURNS) (Burn Degree) |
| Market Size Base Year (Billions) | ~USD 2.42 (2024) |
| Revenue Forecast (Billions) | ~USD 3.35 (2029) |
| Segments Covered | Product, Type, Burn Degree, End User |
4 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| BURN TREATMENT CENTERS | 8.11 | 8.11 | 8.15 | 8.24 | 8.37 | 8.8 | 9.1 | 9.46 | 2.8 |
| HOME CARE SETTINGS | 5.47 | 5.45 | 5.45 | 5.48 | 5.54 | 5.77 | 5.93 | 6.13 | 2.3 |
| HOSPITALS | 31.38 | 31.98 | 32.74 | 33.71 | 34.88 | 37.98 | 39.95 | 42.25 | 4.6 |
| OTHER END USERS | 3.8 | 3.76 | 3.74 | 3.75 | 3.77 | 3.88 | 3.97 | 4.09 | 1.7 |
| PHYSICIAN CLINICS & AMBULATORY CARE SETTINGS | 5.66 | 5.69 | 5.75 | 5.84 | 5.96 | 6.33 | 6.58 | 6.87 | 3.3 |
| TOTAL | 54.41 | 54.98 | 55.83 | 57.03 | 58.52 | 62.77 | 65.53 | 68.79 | 3.8 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HILL-ROM HOLDINGS, INC. | United States | Private Company | Advanced Dressings (Collagen, Film, Hydrogel, Foam, Alginate),Therapy Devices (Debridement, NPWT, Support Surfaces),Biologics, |
| NITTO DENKO CORPORATION | Japan | Public Company | Advanced Dressings – Film & Foam,Advanced Dressings – Hydrogel & Alginate,Advanced Dressings – Collagen, |
| SMITH+NEPHEW | United Kingdom | Public Company | Advanced Dressings (Collagen, Film, Hydrogel, Foam, Alginate),Therapy Devices (Debridement, NPWT),Biologics / Advanced Wound Bioactives, |
| MÖLNLYCKE HEALTH CARE AB | Sweden | Private Company | Advanced Dressings – Foam,Advanced Dressings – Film,Advanced Dressings – Hydrogel, |
| CARDINAL HEALTH INC. | United States | Public Company | Advanced dressings (collagen, film, hydrogel, foam, alginate),Therapy devices (Debridement, NPWT),Biologics, |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | United States | Public Company | Advanced Dressings (Collagen, Film, Hydrogel, Foam, Alginate),Biologics / Dermal Regeneration Matrices,Therapy Devices (Debridement, NPWT), |
| CONVATEC GROUP PLC | United Kingdom | Public Company | Advanced dressings (Collagen, Film, Hydrogel, Foam, Alginate),Therapy devices (Debridement, NPWT),Biologics, |
| COLOPLAST GROUP | Denmark | InvalidIdentifier | Advanced Dressings (Collagen, Film, Hydrogel, Foam, Alginate),Therapy Devices (Debridement, NPWT),Biologics, |
| SOLVENTUM CORPORATION | United States | Public Company | Advanced Dressings (Collagen, Film, Hydrogel, Foam, Alginate),Therapy Devices (Debridement, NPWT),Biologics, |
| ESSITY AKTIEBOLAG | Sweden | Public Company | Advanced Dressings (Collagen, Film, Hydrogel, Foam, Alginate),Therapy Devices (Debridement, NPWT),Biologics, |
| PAUL HARTMANN AG | Germany | Public Company | Advanced Dressings (Collagen, Film, Hydrogel, Foam, Alginate),Therapy Devices (Debridement, NPWT),Biologics, |
| MATIV HOLDINGS, INC. | United States | Public Company | Advanced Dressings (Collagen, Film, Hydrogel, Foam, Alginate),Therapy Devices (Debridement, NPWT) – Components and Interfaces,Biologics – Dressings and Adjacent Substrates, |
| ADVANCED MEDICAL SOLUTIONS GROUP PLC | United Kingdom | Public Company | Advanced dressings (collagen, film, hydrogel, foam, alginate),Therapy devices (Debridement, NPWT),Biologics, |
| ORGANOGENESIS HOLDINGS INC. | United States | Public Company | Advanced dressings (collagen, film, hydrogel, foam, alginate and related advanced wound matrices used in burns),Biologics (placental allografts, bioengineered skin substitutes, tissue scaffolds for burns),Therapy devices (debridement, NPWT used alongside company matrices in burn protocols), |
| VERICEL CORPORATION | United States | Public Company | Biologics (Epicel, NexoBrid),Advanced Dressings (collagen, film, hydrogel, foam, alginate),Therapy Devices (debridement, NPWT), |
Hill-Rom Holdings, Inc. is a United States-based private company founded in 1915 that employs 10,000 people. The company operates in the healthcare equipment and medical device industry.
Nitto Denko Corporation is a Japanese public company founded in 1918 with 26,477 employees. The company manufactures diversified products including films, adhesive tapes, and specialty materials.
Smith+Nephew is a United Kingdom-based public company founded in 1856 with 16,988 employees. The company develops and markets medical devices and wound care products globally.
Mölnlycke Health Care AB is a Swedish private company founded in 1849. The company specializes in medical devices and healthcare solutions.
Cardinal Health Inc. is a United States-based public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals and medical supplies.
Integra LifeSciences Holdings Corporation is a United States-based public company founded in 1989 with 4,427 employees. The company develops and manufactures medical devices for neurosurgery, orthopedics, and regenerative medicine.
ConvaTec Group PLC is a United Kingdom-based public company founded in 1978 with 10,910 employees. The company manufactures and distributes ostomy care, continence care, and wound care products.
Coloplast Group is a Danish company with operations in medical devices and healthcare solutions. The company is a global leader in ostomy care, continence care, and wound care products.
Solventum Corporation is a United States-based public company founded in 2023 with 20,584 employees. The company operates in healthcare and industrial sectors.
Essity Aktiebolag is a Swedish public company founded in 1849 with 36,000 employees. The company produces hygiene and health products including tissue, incontinence care, and medical solutions.
Paul Hartmann AG is a German public company founded in 1818 with 10,066 employees. The company manufactures and distributes medical and healthcare products globally.
Mativ Holdings, Inc. is a United States-based public company founded in 1995 with 5,000 employees. The company produces specialty materials and engineered products for various industries.
Advanced Medical Solutions Group PLC is a United Kingdom-based public company founded in 1991 with 1,800 employees. The company develops and manufactures advanced wound care and surgical products.
Organogenesis Holdings Inc. is a United States-based public company with 854 employees. The company develops and commercializes regenerative medicine products for wound care and surgical applications.
Vericel Corporation is a United States-based public company founded in 1989 with 398 employees. The company develops and manufactures advanced cell therapies for the treatment of severe burns and cartilage damage.
Spain's burn care market is valued at USD 32.2 million in 2024.
Spain's burn care market is projected to reach USD 39.8 million by 2029.
Spain's burn care market is growing at a CAGR of 3.8% from 2024 to 2029.
Growth in Spain is driven by advanced healthcare infrastructure, increased awareness of burn care protocols, aging population demographics, and investment in specialized treatment facilities.
Spain's 3.8% CAGR reflects steady, sustainable growth supported by a well-established healthcare system and strong regulatory environment for medical innovation.
The study involved major activities in estimating the current size of the burn care market. Exhaustive secondary research was done to collect information on the burn care industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the burn care market.
In the secondary research process, a variety of sources were utilized to gather information for this study. These sources included company annual reports, press releases, and investor presentations; white papers; certified publications; articles by recognized authors; reputable websites; and information from regulatory bodies and databases, such as D&B Hoovers, Bloomberg Business, and Factiva.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION |
|---|---|
| Smith+Nephew | Regional Sales Manager |
| Mölnlycke Health Care AB (Sweden) | Clinical Specialist |
Both top-down and bottom-up approaches were used to estimate and validate the burn care market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
The research methodology used to estimate the market size includes the following:

After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
A burn is an injury resulting from the destruction of tissues or the rupture of the membrane. It is caused by flames, fire, hot objects, or liquids. Burn care involves using products such as dressings, devices, and biologics to promote rapid healing of injuries. Burns can range in severity from superficial to deep tissue damage and may lead to complications such as infection or scarring. Burn care products aim to prevent infection, support tissue regeneration, and relieve pain.
Full forecast, segment splits, and company analysis for all Burn Care Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report